Article
Licensed
Unlicensed
Requires Authentication
Proposal for the use in emergency departments of cardiac troponins measured with the latest generation methods in patients with suspected acute coronary syndrome without persistent ST-segment elevation
-
Ivo Casagranda
,
Mario Cavazza
Published/Copyright:
July 26, 2013
Abstract
The purpose of this document is to develop recommendations on the use of the latest generation of cardiac troponins in emergency room settings for the diagnosis of myocardial infarction in patients with suspected acute coronary syndrome (ACS) without persistent ST-segment elevation (NSTE-ACS). The main points which have been addressed reaching a consensus are represented by:
Suitability and appropriateness of the terminology.
Appropriateness of the request.
Confirmation of the diagnosis of myocardial infarction (rule-in).
Exclusion of the diagnosis of myocardial infarction (rule-out).
Work method: Each point has been analyzed by taking into account the evidence presented in medical publications. Recommendations were developed using the criteria adopted by the European Society of Cardiology and the American Heart Association/American College of Cardiology (www.escardio.org/guidelines). Each point of the recommendation was submitted for validation to an external audit by a Group of Experts (named above).
Keywords: acute coronary syndrome; cardiac troponin; emergency departments; high-sensitivity assays; non-ST-segment elevation; 99th percentile
Published Online: 2013-07-26
Published in Print: 2013-09-01
©2013 by Walter de Gruyter Berlin Boston
You are currently not able to access this content.
You are currently not able to access this content.
Articles in the same Issue
- Masthead
- Masthead
- Editorials
- What is a biomarker? It’s time for a renewed definition
- Biomarker research and leading causes of death worldwide: a rather feeble relationship
- Thiosulfate in urine: new hope or new failure of a biomarker for prostate cancer?
- Review
- Acute coronary syndrome – the present and future role of biomarkers1)
- Mini Review
- Advance in molecular diagnostic tools for hepatitis B virus detection
- Opinion Paper
- Standardization and analytical goals for glycated hemoglobin measurement
- Guidelines and Recommendations
- Proposal for the use in emergency departments of cardiac troponins measured with the latest generation methods in patients with suspected acute coronary syndrome without persistent ST-segment elevation
- General Clinical Chemistry and Laboratory Medicine
- Current status of verification practices in clinical biochemistry in Spain
- Two site evaluation of the performance of a new generation point-of-care glucose meter for use in a neonatal intensive care unit
- Trp64Arg (rs4994) polymorphism of β3-adrenergic receptor gene is associated with hyperuricemia in a Chinese male population
- Quantification of vancomycin in human serum by LC-MS/MS
- Automated indirect immunofluorescence antinuclear antibody analysis is a standardized alternative for visual microscope interpretation
- Autocorrelation and cross-correlation between hCGβ and PAPP-A in repeated sampling during first trimester of pregnancy
- Platelet oxidative stress and systemic inflammation in chronic spontaneous urticaria
- Reference Values
- Establishment of reference values for novel urinary biomarkers for renal damage in the healthy population: are age and gender an issue?
- Risks of mortality associated with common laboratory tests: a novel, simple and meaningful way to set decision limits from data available in the Electronic Medical Record
- Cancer Diagnostics
- Cancer antigen 125, human epididymis 4, kallikrein 6, osteopontin and soluble mesothelin-related peptide immunocomplexed with immunoglobulin M in epithelial ovarian cancer diagnosis
- Thiosulfate in urine as a facilitator in the diagnosis of prostate cancer for patients with prostate-specific antigen less or equal 10 ng/mL
- Anemia and iron biomarkers in patients with early breast cancer. Diagnostic value of hepcidin and soluble transferrin receptor quantification1)
- Sensitive detection of EML4-ALK fusion oncoprotein of lung cancer by in situ proximity ligation assay
- Re-evaluation of laboratory predictors of response to current anemia treatment regimens of erythropoiesis stimulating agents in cancer patients
- Cardiovascular Diseases
- Evaluation of four sensitive troponin assays for risk assessment in acute coronary syndromes using a new clinically oriented approach for comparison of assays
- A combined index of cardiac biomarkers as a risk factor for early cardiovascular mortality in hemodialysis patients
- Prognostic utility of biochemical markers of cardiovascular risk: impact of biological variability
- Letters to the Editors
- Exploring the relationship between serum biomarkers, acute intracerebral changes and outcome after severe traumatic brain injury (TBI)
- Laboratory false-positive results: a clinician responsibility or a shared responsibility with requesting clinicians?
- The one hour lactose tolerance test
- High concentration of IgM-κ paraprotein causes over-estimation of serum total protein by certain biuret method
- Determining calculated free testosterone reference intervals in a normal adult male population
- Alveolar neopterin, procalcitonin, and IL-6 in relation to serum levels and severity of lung injury in ARDS
- Falsely elevated cobalamin concentration in multiple assays in a patient with pernicious anemia: a case study
- Leading Figures in Laboratory Medicine
- Research forever – Klaus Jung
Keywords for this article
acute coronary syndrome;
cardiac troponin;
emergency departments;
high-sensitivity assays;
non-ST-segment elevation;
99th percentile
Articles in the same Issue
- Masthead
- Masthead
- Editorials
- What is a biomarker? It’s time for a renewed definition
- Biomarker research and leading causes of death worldwide: a rather feeble relationship
- Thiosulfate in urine: new hope or new failure of a biomarker for prostate cancer?
- Review
- Acute coronary syndrome – the present and future role of biomarkers1)
- Mini Review
- Advance in molecular diagnostic tools for hepatitis B virus detection
- Opinion Paper
- Standardization and analytical goals for glycated hemoglobin measurement
- Guidelines and Recommendations
- Proposal for the use in emergency departments of cardiac troponins measured with the latest generation methods in patients with suspected acute coronary syndrome without persistent ST-segment elevation
- General Clinical Chemistry and Laboratory Medicine
- Current status of verification practices in clinical biochemistry in Spain
- Two site evaluation of the performance of a new generation point-of-care glucose meter for use in a neonatal intensive care unit
- Trp64Arg (rs4994) polymorphism of β3-adrenergic receptor gene is associated with hyperuricemia in a Chinese male population
- Quantification of vancomycin in human serum by LC-MS/MS
- Automated indirect immunofluorescence antinuclear antibody analysis is a standardized alternative for visual microscope interpretation
- Autocorrelation and cross-correlation between hCGβ and PAPP-A in repeated sampling during first trimester of pregnancy
- Platelet oxidative stress and systemic inflammation in chronic spontaneous urticaria
- Reference Values
- Establishment of reference values for novel urinary biomarkers for renal damage in the healthy population: are age and gender an issue?
- Risks of mortality associated with common laboratory tests: a novel, simple and meaningful way to set decision limits from data available in the Electronic Medical Record
- Cancer Diagnostics
- Cancer antigen 125, human epididymis 4, kallikrein 6, osteopontin and soluble mesothelin-related peptide immunocomplexed with immunoglobulin M in epithelial ovarian cancer diagnosis
- Thiosulfate in urine as a facilitator in the diagnosis of prostate cancer for patients with prostate-specific antigen less or equal 10 ng/mL
- Anemia and iron biomarkers in patients with early breast cancer. Diagnostic value of hepcidin and soluble transferrin receptor quantification1)
- Sensitive detection of EML4-ALK fusion oncoprotein of lung cancer by in situ proximity ligation assay
- Re-evaluation of laboratory predictors of response to current anemia treatment regimens of erythropoiesis stimulating agents in cancer patients
- Cardiovascular Diseases
- Evaluation of four sensitive troponin assays for risk assessment in acute coronary syndromes using a new clinically oriented approach for comparison of assays
- A combined index of cardiac biomarkers as a risk factor for early cardiovascular mortality in hemodialysis patients
- Prognostic utility of biochemical markers of cardiovascular risk: impact of biological variability
- Letters to the Editors
- Exploring the relationship between serum biomarkers, acute intracerebral changes and outcome after severe traumatic brain injury (TBI)
- Laboratory false-positive results: a clinician responsibility or a shared responsibility with requesting clinicians?
- The one hour lactose tolerance test
- High concentration of IgM-κ paraprotein causes over-estimation of serum total protein by certain biuret method
- Determining calculated free testosterone reference intervals in a normal adult male population
- Alveolar neopterin, procalcitonin, and IL-6 in relation to serum levels and severity of lung injury in ARDS
- Falsely elevated cobalamin concentration in multiple assays in a patient with pernicious anemia: a case study
- Leading Figures in Laboratory Medicine
- Research forever – Klaus Jung
